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Abstract
Introduction Monitoring cardiac output (CO) may allow early
detection of haemodynamic instability, aiming to reduce
morbidity and mortality in critically ill patients. Continuous
cardiac output (CCO) monitoring is recommended in septic or
postoperative patients with high incidences of intra-abdominal
hypertension (IAH). The aim of the present study was to
compare the agreement between three CCO methods and a
bolus thermodilution CO technique during acute IAH and
volume loading.
Methods Ten pigs were anaesthetised and instrumented for
haemodynamic measurements. Cardiac output was obtained
using CCO by pulse power analysis (PulseCO; LiDCO monitor),
using CCO by pulse contour analysis (PCCO; PiCCO monitor)
and using CCO by pulmonary artery catheter thermodilution
(CCOPAC), and was compared with bolus transcardiopulmonary
thermodilution CO (COTCP) at baseline, after fluid loading, at
IAH and after an additional fluid loading at IAH. Whereas
PulseCO was only calibrated at baseline, PCCO was calibrated
at each experimental step.
Results PulseCO and PCCO underestimated CO, as the
overall bias ± standard deviation was 1.0 ± 1.5 l/min and 1.0 ±
1.1 l/min compared with COTCP. A clinically accepted
agreement between all of the CCO methods and COTCP was
observed only at baseline. Whereas IAH did not influence the
CO, increased CO following fluid loading at IAH was only
reflected by CCOPAC and COTCP, not by uncalibrated PulseCO
and PCCO. After recalibration, PCCO was comparable with
COTCP.
Conclusions The CO obtained by uncalibrated PulseCO and
PCCO failed to agree with COTCP during IAH and fluid loading.
In the critically ill patient, recalibration of continuous arterial
waveform CO methods should be performed after fluid loading
or before a major change in therapy is initiated.
Introduction
Monitoring cardiac output (CO) allows early detection of
haemodynamic instability and may be used to guide intensive
care, aiming to reduce morbidity and mortality in high-risk
patients [1]. In the past decade, continuous cardiac output
(CCO) was commonly obtained by pulmonary artery catheter
(PAC) with integrated heating filaments. The risk–benefit ratio
of right heart catheterisation simply for CO determination has
been questioned due to associated complications and the
availability of less invasive alternatives [2]. Various monitor
devices have been recently introduced into clinical practise
that use the arterial pressure waveform to calculate CO on a
beat-to-beat basis, such as the LiDCO™plus system using
continuous cardiac output by pulse power analysis (PulseCO)
and the PiCCO plus system using continuous cardiac output
by pulse contour analysis (PCCO). Since arterial and central
CCO: continuous cardiac output; CCOPAC: continuous cardiac output by pulmonary artery catheter thermodilution; CO: cardiac output; COTCP: bolus 
transcardiopulmonary thermodilution cardiac output; CVP: central venous pressure; GEDV: global end-diastolic volume; IAH: intra-abdominal hyper-
tension; PAC: pulmonary artery catheter; PAOP: pulmonary artery occlusion pressure; PCCO: continuous cardiac output by pulse contour analysis; 
PCCOpre: continuous cardiac output by pulse contour analysis before calibration; PCCOrecal: continuous cardiac output by pulse contour analysis 
after recalibration; PE: percentage error; PulseCO: continuous cardiac output by pulse power analysis; SD: standard deviation.Critical Care    Vol 12 No 5    Gruenewald et al.
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venous catheters are often already used to monitor critically ill
patients, these techniques are not additionally invasive.
Several clinical studies have been performed on intensive care
patients showing good agreement and correlation of the afore-
mentioned methods of CCO determination with thermodilu-
tion or indicator-based techniques [3-10]. Some authors,
however, recently questioned the reliability of these methods
when acute changes of CO occur [11-14]. Therefore it is of
high clinical interest to know whether the CCO method used
is able to detect sudden CO changes, as frequently observed
during haemorrhage, fluid loading or vasopressor administra-
tion [15]. Moreover, critically ill patients often present with
intra-abdominal hypertension (IAH) [16]. Preliminary data by
Malbrain and colleagues indicated unacceptable high limits of
agreement of different invasive CCO measurements in 10
patients with IAH [17]. Reliability of CCO measurement during
IAH and volume loading has not yet been elucidated in a con-
trolled experimental setup. Increased intra-abdominal pressure
is likely to modify several factors known to impact arterial
waveform, such as chest wall compliance and arterial
elastance, thereby potentially deteriorating agreement
between the CO derived from thermodilution and derived from
the arterial waveform.
The aim of the present study was to investigate whether Pul-
seCO and PCCO – methods derived from the arterial wave-
form – and continuous assessment of continuous cardiac
output by pulmonary artery catheter thermodilution (CCOPAC)
are able to detect a volume-induced change of CO during IAH
when compared with bolus transcardiopulmonary thermodilu-
tion cardiac output (COTCP). Further, the level of agreement
between these CCO values and COTCP during IAH was deter-
mined. Finally, we analysed the impact of calibration on the
accuracy of continuous beat-to-beat CO methods.
Materials and methods
The present study was reviewed and approved by the local
Animal Investigation Committee. The animals (10 healthy Ger-
man domestic pigs, 58 ± 8 kg) were managed in accordance
with our institutional guidelines, which are based on the Guide
for the Care and Use of Laboratory Animals published by the
National Institute of Health (NIH Publication No. 88.23,
revised 1996).
The animals were fasted overnight, but had free access to
water. The pigs were premedicated with the neuroleptic aza-
perone (4 to 8 mg/kg intramuscularly) and atropine (0.01 to
0.05 mg/kg intramuscularly) 1 hour before induction of anaes-
thesia with a bolus dose of ketamine (2 mg/kg intramuscu-
larly), propofol (2 to 4 mg/kg intravenously) and sufentanil (0.3
μg/kg intravenously) given via an ear vein. After intubation with
a cuffed endotracheal tube (internal diameter, 8.5 mm), the
pigs were ventilated using a volume-controlled ventilator
(Avea; Viasys Healthcare, Yorba Linda, CA, USA) with 10 ml/
kg tidal volume, a positive end-expiratory pressure of 5
cmH2O, an inspiration:expiration ratio of 1:1.5 and a fraction
of inspired oxygenof 0.35. The respiratory rate (12 to 18
breaths/min) was adjusted to maintain normocapnea (pres-
sure of end-tidal CO2 = 35 to 45 mmHg). Oxygen saturation
was monitored by a pulse oxymeter placed on the ear (M-
CaiOV; Datex-Ohmeda, Helsinki, Finland).
Anaesthesia was maintained with a continuous infusion of pro-
pofol (6 to 8 mg/kg/hour) and sufentanil (0.3 μg/kg/hour), and
muscle relaxation was provided by continuous infusion of pan-
curonium (0.2 mg/kg/hour) to ensure suppression of sponta-
neous gasping. In our experience, the animals do not respond
to painful or auditory stimuli under this anaesthetic regimen
when the paralysing agent is withheld, and the loading dose of
ketamine and propofol subsides.
Ringer solution (5 ml/kg/hour) was administered during instru-
mentation. For induction of IAH, a Verres needle was inserted
via a small infra-umbilical incision into the intra-abdominal cav-
ity. The Verres needle was then connected to an electronic
variable-flow insufflator (Wolf 2154701; Wolf GmbH, Knittlin-
gen, Germany) for direct intra-abdominal pressure measure-
ment and induction of IAH due to carbon dioxide
pneumoperitoneum. The intra-abdominal pressure was meas-
ured in a supine position at end expiration.
Cardiac output techniques
Pulse power analysis
PulseCO is a method integrated into the LiDCO™plus monitor
(LiDCO™ Systems, London, UK). PulseCO uses pulse power
analysis to determine the CCO by analysing the entire arterial
waveform, and is not based on the morphology of the pulse
contour. The system calculates the nominal stroke volume
after a pressure-to-volume transformation using a curvilinear
pressure/volume relationship. The nominal stroke volume is
converted to the actual stroke volume by calibration of the
algorithm based on lithium dilution using a bolus of 0.002
mmol/kg isotonic lithium chloride that was injected into the
proximal port of the PAC. The lithium dilution curve was meas-
ured by a lithium ion-selective electrode (LiDCO, London, UK)
located in a femoral arterial line, which was connected to the
LiDCO device. Calibration of PulseCO was performed before
muscle relaxation, because neuromuscular blockers may react
with the lithium electrode.
Pulse contour analysis
PCCO is a method integrated into the PiCCO plus monitor
(version 6.0; Pulsion Medical Systems, Munich, Germany).
PCCO uses pulse contour analysis for calculation of the CCO
and is based on a modified algorithm originally described by
Wesseling and colleagues [18]. This algorithm enables con-
tinuous calculation of the stroke volume by measuring the
systolic portion of the aortic pressure waveform and dividing
the area under the curve by the individual aortic impedance.Available online http://ccforum.com/content/12/5/R132
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The PCCO device therefore needs to be calibrated by tran-
scardiopulmonary thermodilution.
Continuous thermodilution by pulmonary artery catheter
CCOPAC is based on a semicontinuous pulsed warm thermodi-
lution technique integrated into a PAC that is connected to a
computer system (Vigilance Monitor; Baxter Edwards Critical
Care, Irvine, CA, USA). The PAC (7.5-Fr Swan–Ganz CCO;
Baxter Healthcare Corporation, Irvine, CA, USA) was inserted
via an 8.5-Fr transducer into the right internal jugular vein for
measuring the central venous pressure (CVP) and the pulmo-
nary artery occlusion pressure (PAOP) and for CCOPAC
recording.
Intermittent bolus transcardiopulmonary thermodilution
COTCP is a bolus transcardiopulmonary thermodilution tech-
nique and served as the reference method and calibration
method for PCCO. A 5-Fr thermistor-tipped arterial catheter
(Pulsion Medical Systems) was inserted percutaneously into
the right femoral artery, which was connected to the PiCCO
plus monitor. A 10 ml bolus of cold (<8°C) saline was injected
three times randomly assigned to the respiratory cycle into the
proximal port of the PAC. Furthermore, an implemented algo-
rithm enables calculation of the global end-diastolic volume
(GEDV) as a volumetric variable of preload.
Experimental protocol
The experimental protocol is presented in Figure 1.
At the end of surgical preparation, at least 15 minutes were
allowed for stabilisation. After taking baseline values, all ani-
mals received a fluid load of 500 ml hydroxyl-ethyl starch 6%.
Equilibrium was expected after 10 minutes and measurements
were repeated. Carbon dioxide was subsequently inflated into
the abdominal cavity. IAH was assumed when the abdominal
pressure was increased to at least 20 mmHg, reaching IAH
grade III/IV according to the 2004 International Abdominal
Compartment Syndrome Consensus Definitions Conference
[19].
CO measurements were recorded after another stabilisation
period of 10 minutes and again after a second fluid load of 500
ml hydroxyl-ethyl starch 6%. We recorded PCCO values 2
minutes before recalibration (PCCOpre) and 2 minutes after
recalibration (PCCOrecal) by COTCP to control for a calibration
effect. To avoid interference of CCOPAC with the bolus of ice-
cold saline for COTCP calibration, COTCP was obtained at least
2 minutes in advance of CCOPAC recording. CCOPAC sam-
pling was started after obtaining the COTCP. PulseCO
remained uncalibrated after baseline calibration throughout
the experimental period. According to the manufacturer, cali-
Figure 1
Experimental protocol Experimental protocol. The methods used were continuous cardiac output by pulse contour analysis (PCCO; PiCCO system), continuous cardiac 
output by pulse power analysis (PulseCO; LiDCO system), continuous cardiac output by pulmonary artery catheter thermodilution (CCOPAC), and 
bolus transcardiopulmonary thermodilution cardiac output (COTCP). PCCO was measured before recalibration (PCCOpre) and after recalibration 
(PCCOrecal) by COTCP. Experimental steps: BL, baseline; + Fluid, fluid loading; IAH, intra-abdominal hypertension; IAH + Fluid, second fluid load at 
IAH. HES, hydroxyl-ethyl starch 6%; IAP, intra-abdominal pressure; n.a., not applicable.Critical Care    Vol 12 No 5    Gruenewald et al.
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bration based on CO measured by lithium dilution or every
other validated CO method is needed only once every 8 hours.
PulseCO, PCCO and CCOPAC values were recorded and
averaged during a period of 1 minute.
Statistical analysis
Data are reported as the mean ± standard deviation (SD)
unless otherwise specified. Statistical comparisons were per-
formed using commercially available statistics software
(GraphPad Prism 4; Graphpad Sofware Inc., San Diego, CA,
USA).
Bland–Altman analysis was used to compare CO values by
different measuring methods [20]. The bias represents the
systemic error between two methods, and was defined as the
mean difference between COA and COB values. Upper and
lower limits of agreement, calculated as the bias ± 2 SDs,
define the range in which 95% of the differences are expected
to lie. The percentage error (PE) was calculated as reported by
Critchley and Critchley [21], as limits of agreement (2 SD)
divided by the mean CO from the two methods:
In addition, data pairs were analysed using linear correlations
and calculation of the coefficient of determination (r2). CO val-
ues after fluid loadings or initiation of IAH were compared
using a paired t test. Furthermore, ΔCO was calculated as the
percentage change of each CO method and was plotted
against  ΔCOTCP using linear regression and Bland–Altman
analysis. P < 0.05 was considered statistically significant.
Results
Nine animals were included in the final analysis. One pig was
excluded from further analysis due to injury of the splenic vein
by the Verres needle and a fatal outcome. All haemodynamic
devices were installed and calibrated properly and no compli-
cations were associated with any of the devices. All animals
were haemodynamically stable throughout the study period,
no arrhythmias occurred, and no inotropic or antihypertensive
drugs were administered. Pneumoperitoneum increased the
intra-abdominal pressure by 17.7 ± 3.5 mmHg, and reduced
chest wall compliance significantly by 64 ± 8%.
The haemodynamic variables are displayed in Table 1. The
mean arterial pressure, GEDV, PulseCO, PCCOpre, PCCOre-
cal, COTCP and CCOPAC significantly increased after fluid load-
ing at baseline, whereas the heart rate, CVP and PAOP
remained unchanged. IAH significantly increased CVP and
PAOP, but did not change the mean arterial pressure, heart
rate, GEDV or CO values. Fluid loading during IAH did not sig-
nificantly change the mean arterial pressure, heart rate, CVP,
PAOP or GEDV, while COTCP, CCOPAC and PCCOrecal indi-
cated a significant increase in CO. PulseCO and PCCOpre,
however, were unable to reflect an increase of CO following
fluid loading during IAH. Changes of CO determined by differ-
ent methods throughout the experimental period are pre-
sented in Figure 2a. Individual time responses of each CO
parameter are presented in detail (see Additional file 1, Figure
S2).
Results of ΔCO comparison by Bland–Altman analysis and lin-
ear regression analysis are presented in Table 2 (for further
details, see Additional file 1, Figure S1). ΔCCOPAC and ΔPC-
COrecal showed better agreement with ΔCOTCP than uncali-
brated ΔPulseCO or ΔPCCOpre.
Bland–Altman analysis revealed an overall (pooled data) bias
± SD (PE) between COTCP and PulseCO of 1.0 ± 1.5 l/min
(41.7%), between COTCP and PCCOpre of 1.0 ± 1.1 l/min
(27.5%), and between COTCP and CCOPAC of 0.0 ± 0.9 l/min
(23.3%). Figure 3a to 3f present Bland–Altman plots and cor-
relation of pooled data comparing PulseCO, PCCOpre and
CCOPAC with COTCP.
The bias and precision (SD) between the examined CO meth-
ods and COTCP at individual experimental steps are displayed
in Figure 2b. The bias between COTCP and the different CO
methods was low at baseline, as criteria of interchangeability
(PE <30%) were observed for all CO methods [21]. Fluid
loading did not change the bias between methods signifi-
cantly. After application of IAH, the bias between COTCP and
PulseCO and between COTCP and PCCOpre increased, but
this was only significant for PCCOpre (P < 0.05). Whereas
fluid loading at baseline did not affect the bias between meth-
ods, the bias between COTCP and PulseCO and between
COTCP and PCCOpre was significantly increased after fluid
loading at IAH (P < 0.05). Calibration of PCCOpre reduced the
bias significantly, as the bias between PCCOrecal and COTCP
was low. Detailed results of Bland–Altman analysis and Pear-
son correlation comparisons between the different CCO
methods and COTCP at individual steps are available (see
Additional file 1, Table S1).
Discussion
The main findings of our experimental animal study are as fol-
lows. Firstly, at baseline without IAH, all CO methods showed
acceptable agreement and reflected volume loading with an
increase in CO. In contrast, IAH affects CO methods based on
arterial waveform analysis in their ability to accurately indicate
an increase in CO following fluid loading. Finally, recalibration
of PCCO restored the system's accuracy.
The present study is the first on the agreement between three
CCO methods and one intermittent bolus-thermodilution CO
method during IAH and subsequent fluid loading. Research in
the field of CCO monitoring has increased in recent years, as
better evaluation of changes in a patient's haemodynamic sta-
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whether these methods are able to reflect acute changes in
CO induced by fluid loading under clinically relevant settings
such as IAH.
Our results showed acceptable agreement of pooled CO data
between COTCP, PCCOpre  + PCCOrecal  and CCOPAC,
whereas continuous beat-to-beat analysis by PulseCO cali-
brated only once underestimated the CO and failed inter-
changeability as defined by Critchley and Critchley [21].
With respect to CCOPAC versus COTCP and CCOPAC versus
PCCO, comparable agreement and correlation have been
reported in several previous studies [22,23]. Compared with
COTCP, PCCOrecal showed lower bias and lower PE than
PCCOpre, a result expected intuitively. Volume loading in addi-
tion to IAH resulted in a significant increase of the CO meas-
ured by thermodilution techniques (CCOPAC and COTCP). In
contrast, beat-to-beat CO methods such as PulseCO and
PCCOpre did not reflect the increase in CO accurately in the
presence of IAH. The bias between PulseCO and PCCOpre
versus COTCP was significant after the second fluid load.
Since the variability of bolus thermodilution is about 15%, we
suggest that a mean bias within 15% of average CO can be
clinically accepted. Recalibration of PCCO, as indicated by
PCCOrecal, results in a significant reduction of bias.
Taken together these findings emphasise that monitors track-
ing beat-to-beat CO benefit from frequent calibrations during
changing loading conditions or changes of variables poten-
tially influencing the underlying calculation algorithm, such as
IAH.
All of the CO monitors showed clinically acceptable [21]
agreement at baseline. The increase of CO due to fluid loading
Figure 2
Distribution and bias of cardiac output methods Distribution and bias of cardiac output methods. (a) Cardiac output (CO) measured by the different CO methods at each experimental step. (b) 
Bias and precision (standard deviation (SD)) between bolus transcardiopulmonary thermodilution cardiac output (COTCP) and the different CO 
methods at each experimental step. PulseCO, continuous cardiac output by pulse power analysis (LiDCO system); PCCO, continuous cardiac out-
put by pulse contour analysis (PiCCO system); CCOPAC, continuous cardiac output by pulmonary artery catheter thermodilution. PCCO was meas-
ured before recalibration (PCCOpre) and after recalibration (PCCOrecal) by COTCP. *P < 0.05 versus the previous experimental stage (PCCOpre 
versus previous PCCOrecal). #Methods not interchangeable according to Critchley and Critchley [21]. Filled symbols, calibrated measures. Experi-
mental steps: BL, baseline; + Fluid, fluid loading; IAH, intra-abdominal hypertension; IAH + Fluid, second fluid load at IAH. IAP, intra-abdominal pres-
sure; na, not applicable; SEM, standard error of the mean.Critical Care    Vol 12 No 5    Gruenewald et al.
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without IAH was also comparably reflected by all CO meth-
ods. The bias between methods remained unchanged. Pul-
seCO failed interchangeability with COTCP, however, as the
PE increased clearly above 30% after fluid loading. Our data
therefore suggest that PulseCO does not reliably indicate
rapid haemodynamic changes following fluid loading. Simi-
larly, Cooper and Muir recently reported PE >90% between
PulseCO and lithium dilution CO after fluid resuscitation in
haemorrhagic dogs [12].
While IAH reduced chest wall compliance and increased the
CVP and PAOP, it did not significantly influence the CO. It is
well known that cardiac filling pressures such as the CVP or
PAOP in patients with IAH may be misleading, by falsely indi-
cating increased preload [24]. Contrarily, preload during IAH
may even be decreased due to substantial reductions in
venous return, which is more pronounced in hypovolaemic
patients. In the present study, however, the GEDV indicated
normovolaemic conditions at baseline and no changes of
preload due to IAH occurred. Consequently, it is not surprising
that CO was not affected by IAH, which has been described
previously [25].
There is still an ongoing debate about CO measurement
derived from arterial waveform analysis and its ability to track
changes of CO. In the present study, uncalibrated CCO meth-
ods were not able to reflect changes in CO appropriately. Sev-
eral studies have shown good agreement of PulseCO with
Table 1
Haemodynamic data at each experimental step
Haemodynamic variable Baseline Fluid loading IAH IAH + Fluid
Mean arterial pressure (mmHg) 77 ± 20 99 ± 18* 109 ± 13* 112 ± 16*
Heart rate (beats/min) 87 ± 18 92 ± 18 92 ± 13 99 ± 12*
Central venous pressure (mmHg) 5 ± 2 7 ± 2 12 ± 4*† 12 ± 3*†
Pulmonary artery occlusion pressure (mmHg) 7 ± 2 11 ± 3 16 ± 6*† 16 ± 3*†
Intra-abdominal pressure (mmHg) 7 ± 2 7 ± 3 25 ± 3*† 27 ± 4*†
Chest wall compliance (ml/cmH2O) 58 ± 24 65 ± 22 22 ± 5*† 21 ± 4*†
Systemic vascular resistance (dyn·s/cm5) 963 ± 392 1006 ± 356 1038 ± 192 994 ± 303
Global end-diastolic volume (ml) 767 ± 164 883 ± 214* 928 ± 172* 997 ± 217*†
PulseCO (l/min) 6.4 ± 2.0 7.1 ± 2.7* 6.8 ± 2.5 7.0 ± 2.8
PCCOpre (l/min) n.a. 7.1 ± 1.1* 6.8 ± 2.0 7.9 ± 1.9
COTCP (l/min) 6.2 ± 1.6 7.5 ± 2.1* 8.0 ± 1.9* 9.4 ± 2.4*†‡
PCCOrecal (l/min) 6.2 ± 1.6 7.5 ± 2.1* 8.0 ± 1.9* 9.4 ± 2.4*†‡
CCOPAC (l/min) 6.4 ± 1.4 7.6 ± 1.4* 7.7 ± 1.5* 9.1 ± 2.1*†‡
Data presented as the mean ± standard deviation. IAH, intra-abdominal hypertension; IAH + Fluid, second fluid load at IAH; PulseCO, continuous 
cardiac output by pulse power analysis; PCCOpre, continuous cardiac output by pulse contour analysis before calibration; COTCP, bolus 
transcardiopulmonary thermodilution cardiac output; PCCOrecal, continuous cardiac output by pulse contour analysis after recalibration; CCOPAC, 
continuous cardiac output by pulmonary artery catheter thermodilution. *P < 0.05 versus BL; †P < 0.05 versus + Fluid; ‡P < 0.05 versus IAH 
(PCCOpre versus previous PCCOrecal). n.a., not applicable.
Table 2
Bland–Altman analysis and linear regression analysis of changes in cardiac output
Bias (%) Precision (%) 95% limits of agreement (%) r2
ΔCOTCP and ΔPulseCO 12 19 -26 to 50 0.38
ΔCOTCP and ΔPCCOpre 14 18 -22 to 51 0.32
ΔCOTCP and ΔPCCOrecal -1 5 -10 to 9 0.94
ΔCOTCP and ΔCCOPAC 2 14 -26 to 30 0.47
Bias (mean difference), precision (standard deviation of bias), 95% limits of agreement, and correlation coefficient (r2) between changes (Δ) of 
CO measured by ΔPulseCO, ΔPCCOpre, ΔPCCOrecal and ΔCCOPAC compared with ΔCOTCP. COTCP, bolus transcardiopulmonary thermodilution 
cardiac output; PulseCO, continuous cardiac output by pulse power analysis; PCCOpre, continuous cardiac output by pulse contour analysis 
before calibration; PCCOrecal, continuous cardiac output by pulse contour analysis after recalibration; CCOPAC, continuous cardiac output by 
pulmonary artery catheter thermodilution.Available online http://ccforum.com/content/12/5/R132
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thermodilution or indicator-based CO methods in postsurgical
intensive care patients [7-9]. On the other hand, Yamashita
and colleagues reported that CO measured by PulseCO was
not interchangeable with thermodilution during cardiac sur-
gery [14]. Cooper and Muir [12] have shown only a moderate
decline of PulseCO after induced haemorrhage in healthy
dogs, with significant bias between PulseCO and lithium indi-
cator dilution CO. The CO changes due to changes of intra-
vascular volume might therefore not be adequately tracked by
PulseCO. The authors concluded that false transformation of
arterial pressure difference by PulseCO and changes of arte-
rial compliance are possible explanations for the lack of accu-
racy to depict changes in CO. In the present study, PulseCO
was only calibrated by the lithium dilution technique at base-
line. Because of continuous application of neuromuscular
blocking agents, a repeated calibration with lithium may be
hampered due to interactions at the lithium electrode [9]. A
calibration with another thermodilution technique is possible
but this does not represent clinical practise and loses the
advantage of being less invasive.
Figure 3
Scatter plots and Bland–Altman plots of pooled data pairs Scatter plots and Bland–Altman plots of pooled data pairs. Scatter plots (left-hand side) and Bland–Altman plots (right-hand side) of pooled 
data pairs between (a) and (b) bolus transcardiopulmonary thermodilution cardiac output (COTCP) and continuous cardiac output by pulse power 
analysis (PulseCO; LiDCO system), (c) and (d) between COTCP and continuous cardiac output by pulse contour analysis before recalibration 
(PCCOpre; PiCCO system), and (e) and (f) between COTCP and continuous cardiac output by pulmonary artery catheter thermodilution (CCOPAC). 
(a), (c), (e) Scatter plots include line of identity (dotted line). (b), (d), (f) Bland–Altman plots include bias (solid lines) and limits of agreement (dotted 
lines).Critical Care    Vol 12 No 5    Gruenewald et al.
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In contrast to PulseCO, PCCO was calibrated at each exper-
imental step. A direct comparison of PCCO and PulseCO in
the present study is therefore difficult. By calibrating PCCO
repeatedly, it was already adjusted to the latest changes of
vascular impedance. Interestingly, both PCCOpre  and Pul-
seCO underestimated CO after fluid loading in the presence
of IAH with high bias compared with COTCP. Our group
recently reported high bias between uncalibrated PCCO and
bolus pulmonary artery thermodilution CO in pigs during
haemorrhage and norepinephrine administration [11]. In this
study, uncalibrated PCCO did not reflect decreased CO as
indicated by the PAC during a phlebotomy of almost 2 l – most
probably due to failure to identify the dicrotic notch during a
substantially increased heart rate. These findings were con-
firmed by Piehl and colleagues [26]. Additionally, Rodig and
colleagues [2] reported a significant increase in bias between
PCCO and COTCP after cardiopulmonary bypass and vaso-
pressor administration, most probably due to an increase in
systemic vascular resistance. Sander and colleagues recom-
mended frequent recalibration of PCCO after cardiopulmo-
nary bypass due to changes in systemic vascular resistance
[27]. In our study, however, systemic vascular resistance had
no influence on the bias between methods.
The PCCO algorithm is based on the windkessel model by
Otto Frank [28], including three major individual properties:
aortic/arterial compliance, characteristic impedance, and
peripheral vascular resistance. Calibration of PCCO by COTCP
enables the PCCO algorithm to correct for these three ele-
ments by calculating individual aortal compliance and sys-
temic vascular resistance, and furthermore adjusting to aortic
impedance. The ability of PCCOpre  to accurately detect
changes in CO due to fluid loading was hampered in the pres-
ence of IAH, however, whereas it was preserved at baseline.
With respect to the effects of IAH, our results suggest that,
due to reduced chest wall compliance, increased pleural and
airway pressures are increasingly transmitted to the cardiac
chambers, thereby reducing effective transmural pressure.
Methods based on arterial waveform analysis are conse-
quently prone to error in reflecting abrupt changes in CO, with-
out an implemented algorithm to detect and correct for
changes in vascular impedance as induced by IAH. The clini-
cian therefore needs to consequently recalibrate the CCO
based on arterial waveform analysis before any major change
in therapy is initiated.
Our study has some limitations. The present study is an animal
study and extrapolation to humans should be done with cau-
tion, and the reader should have this in mind. CCOPAC was
obtained 2 minutes after bolus thermodilution, and hence a
minor influence by recirculation of cold fluid is possible.
Conclusion
All of the examined CO methods showed good agreement at
baseline. There are limitations, however, in the ability of uncal-
ibrated continuous CO methods based on arterial waveform
analysis to accurately track changes in CO after fluid loading
during IAH. The trend for underestimation of CO by PulseCO
and PCCOpre documented in the present study could have
clinical consequences. PCCO and PulseCO should be used
with caution when assessing changes in CO after fluid load-
ing, and should be recalibrated before any major change in
therapy is initiated.
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Key messages
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showed good agreement with COTCP without IAH, and 
reflected an increase in CO following fluid loading.
￿  Induction of IAH due to pneumoperitoneum did not sig-
nificantly influence CO measured by PulseCO, PCCO, 
CCOPAC and COTCP.
￿  At IAH, an increase in CO following fluid loading was 
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￿  Recalibration of CCO parameters based on arterial 
waveform analysis should be done before any major 
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